Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Starpharma hitches ride on Dow deal

January 19th, 2005

Starpharma hitches ride on Dow deal

Abstract:
Melbourne pharmaceutical developer Starpharma Holdings is on the verge of signing a strategic deal with Dow Chemical Company that would shore up its intellectual property position and give it access to an estimated 200 patents in the competitive field of nanotechnology.

The deal, which could be finalised by the end of next week, is expected to involve the transfer of Dow's extensive intellectual property portfolio into Starpharma's subsidiary Dendritic Nanotechnologies (DNT). In return, Dow will receive a 31 per cent equity stake in DNT.

Source:
theage

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Starpharma Holdings

Dow Chemical Company

Dendritic Nanotechnologies

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanoelectronics

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

Non-linear effects in coupled optical microcavities August 5th, 2021

Researchers tame silicon to interact with light for next-generation microelectronics June 11th, 2021

Using the environment to control quantum devices: A deeper understanding of how the environment impacts quantum behaviour is bringing quantum devices one step closer to widespread adoption June 1st, 2021

Announcements

Using quantum Parrondo’s random walks for encryption: Asst Prof Kang Hao Cheong and his research team from SUTD have set out to apply concepts from quantum Parrondo’s paradox in search of a working protocol for semiclassical encryption October 15th, 2021

Cellular environments shape molecular architecture: Researchers glean a more complete picture of a structure called the nuclear pore complex by studying it directly inside cells October 15th, 2021

How to program DNA robots to poke and prod cell membranes: A discovery of how to build little blocks out of DNA and get them to stick to lipids has implications for biosensing and mRNA vaccines October 15th, 2021

Molecular Sciences Software Institute receives $15 million grant from National Science Foundation October 15th, 2021

Patents/IP/Tech Transfer/Licensing

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

A new study published on the cover of Science could bolster the development of batteries, fuel cells, 3D printing technologies and more May 1st, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project